First image of the tested substance
First image of the tested substance
Second image of the tested substance
First image of the tested substance
Second image of the tested substance
Second image of the tested substance

Active ingredients and content

Ethylbromazolam

Quantity not determinable

Details of the substance tested

Thickness

4.0 mm

Length x width

15.2 x 5.1 mm

Diameter

Weight

346.8 mg

Colour

White

Colour

Fracture groove

Yes

Relevant substance(s)

Alprazolam (Xanax®)

Learn more

New Psychoactive Substances (NPS)

Learn more

Risk assessment

This tablet sold on the Darknet as bromazolam did not contain bromazolam, but ethylbromazolam.

Ethylbromazolam is structurally related to bromazolam and, like alprazolam (XANAX), belongs to the benzodiazepine group. It is a relatively new, unknown substance for which no clinical studies are available. According to user reports, the effect of ethylbromazolam is comparable to bromazolam. Both are illegally manufactured and not medically approved NPS (New Psychoactive Substance). NPS are generally relatively unresearched substances, which is why the consumption of ethyl bromazolam poses an unknown health risk.

The tested tablet was labeled "XANAX". When such a tablet is purchased, it is normally assumed that it contains the active ingredient alprazolam. Ethylbromazolam is dosed slightly higher than alprazolam, but if additional doses are taken to achieve an effect typical of alprazolam, the risk of a dangerous overdose increases.

Ethylbromazolam has a sedative and sleep-promoting effect and, at 6-20 hours, has a significantly longer effect than alprazolam. According to user reports, there are also reports of after-effects and side effects lasting several days. Possible adverse effects include memory loss, confusion, muscle weakness, drowsiness, dizziness, headaches and nausea. Ethylbromazolam has a strong depressant effect on the central nervous system and therefore carries a high risk of overdose.

Mixed use with other depressant substances (e.g. alcohol and GHB/GBL) and dissociatives (e.g. ketamine) can lead to unconsciousness and life-threatening respiratory depression.

Medicines bought on the black market are often misdeclared. It is therefore essential to test them first or use a drug checker!

Alert level

Safer Use

Analysis

Have your substance tested in a drug check if you bought it on the black market or on the internet. Counterfeit blisters may look identical to the original packaging.

Mixed use

Do not mix any depressant substances such as benzodiazepines, alcohol, GHB/GBL or opioids. Risk of unconsciousness or respiratory paralysis!

Dosage

Feel your way to the dosage and do not rely on dosage information from friends. Various factors such as habituation or dependence can contribute to a greatly increased dosage!

Testing

If you do not have the possibility to have substances analyzed, first test a maximum of one third of the pill. Some counterfeit drugs contain a more potent substance than the original.

Wait and see

Wait at least 2 hours after taking the drug. With some drugs, the onset of the intoxicating effect is very slow or it is difficult to perceive.

Similar warnings

There are no current warnings for this substance

Things to know